JPH04360834A - Keratotic reproduction inhibitor - Google Patents
Keratotic reproduction inhibitorInfo
- Publication number
- JPH04360834A JPH04360834A JP13783091A JP13783091A JPH04360834A JP H04360834 A JPH04360834 A JP H04360834A JP 13783091 A JP13783091 A JP 13783091A JP 13783091 A JP13783091 A JP 13783091A JP H04360834 A JPH04360834 A JP H04360834A
- Authority
- JP
- Japan
- Prior art keywords
- keratotic
- plugs
- keratotic plugs
- acid
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003112 inhibitor Substances 0.000 title claims abstract description 14
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 11
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 11
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 11
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 11
- 229940033123 tannic acid Drugs 0.000 claims abstract description 11
- 229920002258 tannic acid Polymers 0.000 claims abstract description 11
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 10
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960000458 allantoin Drugs 0.000 claims abstract description 6
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims abstract description 6
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims abstract description 3
- 239000011592 zinc chloride Substances 0.000 claims abstract description 3
- 235000005074 zinc chloride Nutrition 0.000 claims abstract description 3
- 229960001939 zinc chloride Drugs 0.000 claims abstract description 3
- 239000011787 zinc oxide Substances 0.000 claims abstract description 3
- 229960001296 zinc oxide Drugs 0.000 claims abstract description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 3
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 3
- 230000008929 regeneration Effects 0.000 claims description 15
- 238000011069 regeneration method Methods 0.000 claims description 15
- 102000011782 Keratins Human genes 0.000 claims description 14
- 108010076876 Keratins Proteins 0.000 claims description 14
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- 239000011148 porous material Substances 0.000 abstract description 23
- 150000001875 compounds Chemical class 0.000 abstract description 12
- 229920000642 polymer Polymers 0.000 abstract description 11
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- -1 chlorohydroxyaluminum Chemical compound 0.000 abstract description 6
- 125000003277 amino group Chemical group 0.000 abstract description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 abstract 1
- 239000000178 monomer Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XQBHAZDVLGNSOJ-UHFFFAOYSA-N 1-(4-ethenylphenyl)-n,n-dimethylmethanamine Chemical compound CN(C)CC1=CC=C(C=C)C=C1 XQBHAZDVLGNSOJ-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 2
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical class C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 125000004663 dialkyl amino group Chemical group 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- SDYRIBONPHEWCT-UHFFFAOYSA-N n,n-dimethyl-2-phenylethenamine Chemical compound CN(C)C=CC1=CC=CC=C1 SDYRIBONPHEWCT-UHFFFAOYSA-N 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- UZMZRFVLRULBOV-UHFFFAOYSA-N 2-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]acetate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CC([O-])=O UZMZRFVLRULBOV-UHFFFAOYSA-N 0.000 description 1
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 description 1
- ZQRNRKASNNVFAJ-UHFFFAOYSA-N 3-[dimethyl(2-prop-2-enoyloxyethyl)azaniumyl]propane-1-sulfonate Chemical compound [O-]S(=O)(=O)CCC[N+](C)(C)CCOC(=O)C=C ZQRNRKASNNVFAJ-UHFFFAOYSA-N 0.000 description 1
- BCAIDFOKQCVACE-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propane-1-sulfonate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCCS([O-])(=O)=O BCAIDFOKQCVACE-UHFFFAOYSA-N 0.000 description 1
- OIETYYKGJGVJFT-UHFFFAOYSA-N 3-[dimethyl-[3-(2-methylprop-2-enoylamino)propyl]azaniumyl]propane-1-sulfonate Chemical compound CC(=C)C(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O OIETYYKGJGVJFT-UHFFFAOYSA-N 0.000 description 1
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical group O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- VRAIHTAYLFXSJJ-UHFFFAOYSA-N alumane Chemical compound [AlH3].[AlH3] VRAIHTAYLFXSJJ-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- COVFEVWNJUOYRL-UHFFFAOYSA-N digallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 COVFEVWNJUOYRL-UHFFFAOYSA-N 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- QYUMESOEHIJKHV-UHFFFAOYSA-M prop-2-enamide;trimethyl(propyl)azanium;chloride Chemical compound [Cl-].NC(=O)C=C.CCC[N+](C)(C)C QYUMESOEHIJKHV-UHFFFAOYSA-M 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- XFTALRAZSCGSKN-UHFFFAOYSA-M sodium;4-ethenylbenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=C(C=C)C=C1 XFTALRAZSCGSKN-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- ZTWTYVWXUKTLCP-UHFFFAOYSA-N vinylphosphonic acid Chemical compound OP(O)(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は毛穴の角栓除去後、角栓
の再生を抑制する角栓再生抑制剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a keratotic plug regeneration inhibitor that inhibits the regeneration of keratotic plugs after removal of keratotic plugs from pores.
【0002】0002
【従来の技術及び発明が解決しようとする課題】最近の
女性の肌の悩みで、上位を占めるものの一つとして毛孔
の目立ちが挙げられる。この原因としては、毛孔に形成
される角栓に起因するところが大きい。角栓は皮脂と共
に汚れを含んで角化して毛孔につまったものであり、こ
れを放置することは、毛孔の目立ちのみならず、肌の種
々のトラブルをひき起こす。従って、角栓を除去するこ
とが、美容上及び肌の健康上好ましい。[Prior Art and Problems to be Solved by the Invention] One of the most common skin concerns faced by women these days is the visibility of pores. This is largely due to the keratotic plugs that form in the pores. A keratin plug contains sebum and dirt, turns into a keratin, and becomes clogged in the pores, and if left untreated, it not only makes the pores more noticeable, but also causes various skin problems. Therefore, it is preferable to remove the keratotic plug from the viewpoint of beauty and skin health.
【0003】しかしながら、角栓は一度の除去のみでは
不十分である。すなわち、角栓を除去した後の毛穴は、
除去後1〜2日目には、いったん小さくなるが、10日
〜2週間程度で角栓が再生して毛穴は、もとの大きさに
戻ってしまう。[0003] However, removing the keratotic plug only once is not sufficient. In other words, the pores after removing the keratin plug are
The size of the keratin plug temporarily decreases within 1 to 2 days after removal, but within 10 days to 2 weeks, the keratin plug regenerates and the pore returns to its original size.
【0004】これに対し、毛穴を引き締め、毛穴を目立
ちにくくするという化粧水が市販されているが、角栓の
再生防止に対しては、ほとんど効果がないものである。
従って、角栓の再生を有効に抑制することのできる角栓
再生抑制剤が望まれていた。[0004] On the other hand, lotions are available on the market that tighten pores and make them less noticeable, but they have almost no effect on preventing the regeneration of keratin plugs. Therefore, there has been a desire for an inhibitor of keratotic plug regeneration that can effectively suppress the regeneration of keratotic plugs.
【0005】[0005]
【課題を解決するための手段】斯かる実状に鑑み本発明
者は鋭意研究を行なった結果、タンニン酸等を一定量含
有する角栓再生抑制剤が、角栓除去後の一時的に収縮し
た毛穴に再び角栓が生成するのを抑制し、毛穴の目立ち
を少なくすることを見出し本発明を完成した。[Means for Solving the Problems] In view of the above-mentioned circumstances, the present inventor conducted intensive research and found that a keratotic plug regeneration inhibitor containing a certain amount of tannic acid etc. temporarily contracted after removal of the keratotic plug. The present invention was completed by discovering that the re-generation of keratin plugs in pores can be suppressed and the pores can be made less conspicuous.
【0006】すなわち本発明は、タンニン酸、酸化亜鉛
、硫酸亜鉛、塩化亜鉛、硫酸アルミニウムカリウム、ク
ロルヒドロキシアルミニウム、アラントインクロルヒド
ロキシアルミニウム及びアラントインジヒドロキシアル
ミニウムより選ばれる1種又は2種以上を含有すること
を特徴とする角栓再生抑制剤を提供するものである。[0006] That is, the present invention includes one or more selected from tannic acid, zinc oxide, zinc sulfate, zinc chloride, potassium aluminum sulfate, aluminum chlorohydroxy, aluminum allantoin chlorohydroxy, and aluminum aluminum allantoin dihydroxy. The present invention provides a characteristic keratotic plug regeneration inhibitor.
【0007】ここで用いるタンニン酸は、m−ガロイル
没食子酸を意味し、植物から抽出されたタンニンの加水
分解によって得られる。斯かるタンニン酸としては、精
製されたものを用いてもよいが、タンニンの加水分解物
をそのまま用いることもできる。本発明の角栓再生抑制
剤中へのタンニン酸等の配合量は0.01〜10重量%
(以下、単に「%」で示す)であるが、特に0.1 〜
5%とすることが好ましい。0.01%より少ないと角
栓再生抑制効果が十分でなく、これが10%を超えて用
いても効果にあまり差がないので好ましくない。[0007] Tannic acid as used herein means m-galloyl gallic acid, which is obtained by hydrolysis of tannins extracted from plants. As such tannic acid, purified tannic acid may be used, but tannin hydrolyzate may also be used as it is. The amount of tannic acid etc. contained in the keratotic plug regeneration inhibitor of the present invention is 0.01 to 10% by weight.
(hereinafter simply indicated as "%"), but in particular 0.1 to
It is preferable to set it to 5%. If it is less than 0.01%, the effect of suppressing the regeneration of keratotic plugs will not be sufficient, and if it is used in excess of 10%, there will not be much difference in the effect, which is not preferable.
【0008】本発明の角栓再生抑制剤には、上記必須成
分の他に通常の化粧料に用いられる成分を必要に応じて
配合してもよい。この成分としては、水、エタノール、
多価アルコール、水溶性高分子、塩、塩基、酸、香料、
色素、防腐剤、紫外線吸収剤、金属キレート剤、油剤、
界面活性剤、ビタミン、美肌成分、殺菌剤、消炎剤、粘
度調整剤、可溶化剤等が挙げられる。[0008] In addition to the above-mentioned essential ingredients, the keratotic plug regeneration inhibitor of the present invention may optionally contain ingredients used in ordinary cosmetics. These ingredients include water, ethanol,
Polyhydric alcohols, water-soluble polymers, salts, bases, acids, fragrances,
Pigments, preservatives, ultraviolet absorbers, metal chelating agents, oils,
Examples include surfactants, vitamins, skin-beautifying ingredients, bactericides, anti-inflammatory agents, viscosity modifiers, solubilizers, and the like.
【0009】本発明の角栓再生抑制剤は常法により製造
され、その剤型は特に限定されず、液状、ペースト状、
粉末状、顆粒状、固形状等とすることができるが、取扱
いの面から、液状又はペースト状とすることが好ましい
。The keratotic plug regeneration inhibitor of the present invention is produced by a conventional method, and its dosage form is not particularly limited, and may be liquid, paste, or
It can be in the form of powder, granules, solid, etc., but from the viewpoint of handling, it is preferably in the form of liquid or paste.
【0010】本発明の角栓再生抑制剤を使用するには、
まず毛穴につまった角栓を除去する必要がある。角栓の
除去手段は特に制限されないが、以下に記すような塩生
成基を有する高分子化合物を含有することを特徴とする
角栓除去剤を用いることにより、有効に除去することが
できる。ここで用いられる高分子化合物の塩生成基とし
ては、酸又は塩基の存在により塩を形成する基であれば
特に制限されず、アニオン性、カチオン性、両イオン性
のいずれの基であってもよい。斯かる塩生成基の具体例
としては、カルボキシル基、スルホン酸残基、硫酸残基
、リン酸残基、硝酸残基、アミノ基、アンモニウム基等
が挙げられる。これらの基は一つの化合物にて2種以上
含まれていてもよい。[0010] To use the keratotic plug regeneration inhibitor of the present invention,
First, you need to remove the keratin plugs that are clogging your pores. The means for removing keratotic plugs is not particularly limited, but they can be effectively removed by using a keratotic plug removing agent characterized by containing a polymer compound having a salt-forming group as described below. The salt-forming group of the polymer compound used here is not particularly limited as long as it forms a salt in the presence of an acid or base, and may be any anionic, cationic, or amphoteric group. good. Specific examples of such salt-forming groups include carboxyl groups, sulfonic acid residues, sulfuric acid residues, phosphoric acid residues, nitric acid residues, amino groups, and ammonium groups. Two or more types of these groups may be contained in one compound.
【0011】また、これらの高分子化合物は水溶性であ
ることが美観上好ましいが、濁っていてもかまわない。[0011]Although it is preferable for aesthetics that these polymer compounds be water-soluble, they may be cloudy.
【0012】斯かる高分子化合物の具体例としては天然
或いは半合成のものとしては、ムコ多糖類であるヒアル
ロン酸、ヒアルロン酸Na、コンドロイチン硫酸Na;
ヘミセルロース類であるアルギン酸、アルギン酸Na、
アルギン酸アンモニウム、カルボキシメチルセルロース
Na塩、カルボキシメチルアミロースが挙げられるが、
合成系のものがより好ましく、合成系のものとしては下
記のモノマーの1種又は2種以上を重合させたもの又は
これらのモノマーと(メタ)アクリル酸エステル、スチ
レン等のビニル系モノマーといった他の一般のモノマー
との共重合体、更にこれらの重合体の混合物が挙げられ
る。Specific examples of such polymer compounds, natural or semi-synthetic, include mucopolysaccharides hyaluronic acid, sodium hyaluronate, and sodium chondroitin sulfate;
Hemicelluloses alginic acid, sodium alginate,
Examples include ammonium alginate, carboxymethylcellulose Na salt, and carboxymethylamylose.
Synthetic ones are more preferable, and examples of synthetic ones include those obtained by polymerizing one or more of the following monomers, or a combination of these monomers and other vinyl monomers such as (meth)acrylic acid ester and styrene. Examples include copolymers with common monomers and mixtures of these polymers.
【0013】アニオン性:アクリル酸(AA)、メタク
リル酸(MA)、マレイン酸、イタコン酸等の不飽和カ
ルボン酸モノマー又はそれらの無水物又はそれらの塩;
スチレンスルホン酸、2−アクリルアミド−2−メチル
プロパンスルホン酸(AMPS)等の不飽和スルホン酸
モノマー又はこれらの塩;ビニルホスホン酸、アシッド
・ホスホキシエチル(メタ)アクリレート等の不飽和リ
ン酸モノマー。Anionic: unsaturated carboxylic acid monomers such as acrylic acid (AA), methacrylic acid (MA), maleic acid, itaconic acid, or their anhydrides or salts thereof;
Unsaturated sulfonic acid monomers or salts thereof such as styrene sulfonic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS); unsaturated phosphoric acid monomers such as vinylphosphonic acid and acid phosphoxyethyl (meth)acrylate.
【0014】カチオン性:ジメチルアミノエチルアクリ
レート(DMAEA )、ジメチルアミノエチルメタク
リレート(DMAEMA)、アクリルアミドプロピルト
リメチルアンモニウムクロライド(DMAPAAm )
等のジアルキルアミノ基を有する(メタ)アクリル酸エ
ステル又は(メタ)アクリルアミド類;ジメチルアミノ
スチレン(DMASt )、ジメチルアミノメチルスチ
レン(DMAMSt)等のジアルキルアミノ基を有する
スチレン類;4−ビニルピリジン、2−ビニルピリジン
等のビニルピリジン類;又はこれらのハロゲン化アルキ
ル、ハロゲン化ベンジル、アルキル若しくはアリールス
ルホン酸又は硫酸ジアルキル等の公知の四級化剤を用い
て四級化したもの。Cationic: dimethylaminoethyl acrylate (DMAEA), dimethylaminoethyl methacrylate (DMAEMA), acrylamidepropyltrimethylammonium chloride (DMAPAAm)
(meth)acrylic acid esters or (meth)acrylamides having a dialkylamino group such as; styrenes having a dialkylamino group such as dimethylaminostyrene (DMASt) and dimethylaminomethylstyrene (DMAMSt); 4-vinylpyridine, 2 - Vinylpyridines such as vinylpyridine; or those quaternized using known quaternizing agents such as alkyl halides, benzyl halides, alkyl or arylsulfonic acids, or dialkyl sulfates.
【0015】両イオン性:N−(3−スルホプロピル)
−N−アクリロイルオキシエチル−N,N−ジメチルア
ンモニウムベタイン、N−(3−スルホプロピル)−N
−メタクリロイルアミドプロピル−N,N−ジメチルア
ンモニウムベタイン、N−(3−カルボキシメチル)−
N−メタクリロイルアミドプロピル−N,N−ジメチル
アンモニウムベタイン、N−(3−スルホプロピル)−
N−メタクリロイルオキシエチル−N,N−ジメチルア
ンモニウムベタイン、N−カルボキシメチル−N−メタ
クリロイルオキシエチル−N,N−ジメチルアンモニウ
ムベタイン。Zwitterionic: N-(3-sulfopropyl)
-N-acryloyloxyethyl-N,N-dimethylammonium betaine, N-(3-sulfopropyl)-N
-methacryloylamidopropyl-N,N-dimethylammonium betaine, N-(3-carboxymethyl)-
N-methacryloylamidopropyl-N,N-dimethylammonium betaine, N-(3-sulfopropyl)-
N-methacryloyloxyethyl-N,N-dimethylammonium betaine, N-carboxymethyl-N-methacryloyloxyethyl-N,N-dimethylammonium betaine.
【0016】なお、これらの高分子化合物の塩生成基が
イオン化されていない場合は、既存の酸、例えば塩酸、
硫酸等の無機塩;酢酸、プロピオン酸、乳酸、コハク酸
、グリコール酸等の有機酸、又は塩基、例えばトリメチ
ルアミン、トリエチルアミン等の三級アミン類;アンモ
ニア、水酸化ナトリウム等により中和等し、イオン化す
ることが好ましい。[0016] If the salt-forming groups of these polymer compounds are not ionized, existing acids such as hydrochloric acid,
Inorganic salts such as sulfuric acid; organic acids such as acetic acid, propionic acid, lactic acid, succinic acid, and glycolic acid; or bases, such as tertiary amines such as trimethylamine and triethylamine; neutralized with ammonia, sodium hydroxide, etc., and ionized. It is preferable to do so.
【0017】また、これらの高分子化合物の分子量は、
1万〜150万の範囲のものが好ましく、特に10万〜
100万のものが好ましい。分子量が1万未満であると
、造膜したフィルムの強度が不十分で、皮膚に対する緊
張感が弱くなり、剥離時に破れ易くなり、一方150万
を超えるものの製造は難しい。[0017] Furthermore, the molecular weight of these polymer compounds is
Those in the range of 10,000 to 1,500,000 are preferred, particularly 100,000 to 1,500,000.
One million is preferred. If the molecular weight is less than 10,000, the strength of the formed film will be insufficient, the tension on the skin will be weak, and it will be easy to tear when peeled off, while on the other hand, it will be difficult to produce a film with a molecular weight of more than 1,500,000.
【0018】この角栓除去剤に用いる上記高分子化合物
の配合量は0.01〜70%、特に5〜40%とするこ
とが好ましい。The amount of the above-mentioned polymer compound used in this keratotic plug remover is preferably 0.01 to 70%, particularly 5 to 40%.
【0019】上記の合成高分子化合物は、溶剤に溶解せ
しめて使用されるが、この溶剤としては、該高分子化合
物を安定に溶解でき更に皮膚に安全なものであれば特に
限定されず、例えば水、エタノール、イソプロピルアル
コール(IPA)等が挙げられる。この溶剤の配合量は
、高分子化合物、任意成分、剤型により適宜決定すれば
よいが、一般的には30〜99.99 %、特に60〜
95%が好ましい。The above-mentioned synthetic polymer compound is used after being dissolved in a solvent, but the solvent is not particularly limited as long as it can stably dissolve the polymer compound and is safe for the skin, such as Examples include water, ethanol, isopropyl alcohol (IPA), and the like. The blending amount of this solvent may be appropriately determined depending on the polymer compound, optional components, and dosage form, but it is generally 30 to 99.99%, particularly 60 to 99.99%.
95% is preferred.
【0020】また角栓除去剤の剤型は、パック剤の他、
綿布、スフ布、テトロン、ナイロン等の織布又はプラス
チックシート等に塗り、パップ剤としてもよい。[0020] In addition to the pack agent, the dosage form of the keratotic plug remover is
It may be applied to cotton cloth, soft cloth, woven cloth such as Tetoron, nylon, or plastic sheet, and used as a poultice.
【0021】この角栓除去剤の製造は、通常のパック剤
やパップ剤の製造方法に準じて行なうことができる。更
にこの角栓除去剤を用いて、角栓を除去する方法は、通
常のパック剤、パップ剤の使用方法と同様にすればよい
。すなわち、例えばパック剤の場合、皮膚に塗布し、乾
燥後ピールオフすればよい。[0021] This keratotic plug remover can be produced in accordance with the manufacturing method of ordinary packs and poultices. Furthermore, the method for removing keratotic plugs using this keratotic plug remover may be the same as the method for using ordinary packs and poultices. That is, for example, in the case of a pack agent, it may be applied to the skin, dried and then peeled off.
【0022】[0022]
【発明の効果】本発明の角栓再生抑制剤を用いれば、角
栓除去後の毛穴に再び、角栓が生成するのを遅らせるこ
とができ、また再生する角栓も小さく保つことができる
。従って、毛穴を目立たなくすることができる。[Effects of the Invention] By using the keratotic plug regeneration inhibitor of the present invention, it is possible to delay the regeneration of keratotic plugs in the pores after removal of the keratotic plugs, and it is also possible to keep the regenerated keratotic plugs small. Therefore, pores can be made less noticeable.
【0023】[0023]
【実施例】以下、実施例を挙げて本発明を更に詳細に説
明するが、本発明はこれに限定されるものではない。
実施例1
男女3名ずつ計6名のパネラーの鼻部の両側にp−スチ
レンスルホン酸ナトリウム/メタクリル酸(1/1)共
重合体20%水溶液を0.1ml ずつほぼ均一に塗布
し、乾燥後剥離し角栓を除去した。ついで、各々鼻部の
一方にはタンニン酸1%水溶液を0.1ml ずつ塗布
し、もう一方はブランクとした。タンニン酸の塗布は朝
と晩、1日2回行ない、これを3日行なった。[Examples] The present invention will be explained in more detail below with reference to Examples, but the present invention is not limited thereto. Example 1 0.1 ml of a 20% aqueous solution of sodium p-styrene sulfonate/methacrylic acid (1/1) copolymer was applied almost uniformly to both sides of the nose of a total of six panelists, three men and three women, and dried. After exfoliation, the keratotic plug was removed. Next, 0.1 ml of a 1% aqueous tannic acid solution was applied to one side of each nose, and the other side was left blank. Tannic acid was applied twice a day, in the morning and at night, for 3 days.
【0024】角栓除去直後と3日後の毛穴の面積を下記
測定法により測定した。結果を表1に示す。
角栓生成率測定法:同一毛穴を測定するためにあらかじ
め撮影した臨床写真と照らし合わせながら、観察する毛
穴を決定し、2mm四方の枠を貼って200倍のDSA
(ダイレクトスキンアナライザー:花王(株)製)で
観察した。このDSA 像を画像解析することによって
、角栓除去処理直後、角栓が抜けた毛穴数と3日後、角
栓が再生している毛穴数を測定し、次式(1)により角
栓生成率を求めた。なお、毛穴は1人片側30個ずつ測
定し、個々に平均値をとり表1に示した。[0024] Immediately after the removal of the keratotic plug and 3 days later, the area of the pore was measured using the following measuring method. The results are shown in Table 1. Measurement method for keratin plug formation rate: Determine the pore to be observed by comparing it with a clinical photograph taken in advance to measure the same pore, paste a 2 mm square frame, and measure the DSA at 200x magnification.
(Direct Skin Analyzer: manufactured by Kao Corporation). By image analysis of this DSA image, the number of pores from which keratin plugs have come out immediately after the keratin plug removal treatment and the number of pores where keratin plugs have regenerated after 3 days are measured, and the keratin plug generation rate is calculated using the following formula (1). I asked for In addition, 30 pores were measured on each side of each person, and the average value was taken for each individual and is shown in Table 1.
【0025】[0025]
【数1】[Math 1]
【0026】[0026]
【表1】[Table 1]
【0027】実施例2 角栓除去後のケア剤(リ
キットタイプ):
(%) タンニン
酸
1.5 ソルビット
2.0 グリセリン
3
.0 ポリオキシエチレンオレイルエーテル(20E
.O.) 1.0
エタノール
15.0 香料
0.2
精製水
バランス量Example 2 Care agent after removal of keratotic plug (liquid type):
(%) Tannic acid
1.5 Sorbit
2.0 Glycerin
3
.. 0 Polyoxyethylene oleyl ether (20E
.. O. ) 1.0
ethanol
15.0 Fragrance
0.2
purified water
balance amount
【0028】実施例3
角栓除去後のケア剤(クリームタイプ):Example 3
Care agent after removing keratotic plug (cream type):
Claims (1)
化亜鉛、硫酸アルミニウムカリウム、クロルヒドロキシ
アルミニウム、アラントインクロルヒドロキシアルミニ
ウム及びアラントインジヒドロキシアルミニウムより選
ばれる1種又は2種以上を含有することを特徴とする角
栓再生抑制剤。[Claim 1] Containing one or more selected from tannic acid, zinc oxide, zinc sulfate, zinc chloride, potassium aluminum sulfate, aluminum chlorohydroxy, aluminum allantoin chlorhydroxy, and aluminum dihydroxy allantoin. Keratin plug regeneration inhibitor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03137830A JP3084085B2 (en) | 1991-06-10 | 1991-06-10 | Keratin plug regeneration inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03137830A JP3084085B2 (en) | 1991-06-10 | 1991-06-10 | Keratin plug regeneration inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04360834A true JPH04360834A (en) | 1992-12-14 |
JP3084085B2 JP3084085B2 (en) | 2000-09-04 |
Family
ID=15207839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP03137830A Expired - Fee Related JP3084085B2 (en) | 1991-06-10 | 1991-06-10 | Keratin plug regeneration inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3084085B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637606A (en) * | 1994-06-10 | 1997-06-10 | Matsumoto; Toshihiro | Hair grower based on allantoin or derivatives thereof |
WO1997027837A1 (en) * | 1996-02-02 | 1997-08-07 | Slavko Dokmann | New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use |
-
1991
- 1991-06-10 JP JP03137830A patent/JP3084085B2/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637606A (en) * | 1994-06-10 | 1997-06-10 | Matsumoto; Toshihiro | Hair grower based on allantoin or derivatives thereof |
WO1997027837A1 (en) * | 1996-02-02 | 1997-08-07 | Slavko Dokmann | New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use |
Also Published As
Publication number | Publication date |
---|---|
JP3084085B2 (en) | 2000-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6306382B1 (en) | Keratotic plug remover | |
US5221533A (en) | Skin lotion composition | |
US4147782A (en) | Pharmaceutical detergent composition | |
KR101508168B1 (en) | Keratotic plug regrowth inhibition agent, keratotic plug regrowth inhibition method, and keratotic plug regrowth inhibition kit | |
AU707853B2 (en) | Dermatological preparation and method for treating actinic keratoses | |
EP0826364A2 (en) | Keratotic plug remover | |
JP3084086B2 (en) | Keratin plug regeneration inhibitor | |
JP2002080401A (en) | Gel composition for external preparation | |
JP2509894B2 (en) | Detergent composition | |
JPH10298026A (en) | Pack material | |
KR20010023182A (en) | Cleansing compositions | |
JP2920443B2 (en) | Keratin plug remover | |
JPH04360834A (en) | Keratotic reproduction inhibitor | |
JP5400196B2 (en) | Square plug regeneration inhibitor | |
JP2003226636A (en) | Weak-acidic cleansing preparation | |
JP3455120B2 (en) | Pack cosmetics | |
JP3578776B2 (en) | Square plug removal method | |
WO1999038473A2 (en) | Cosmetic product kit | |
JP3238789B2 (en) | Alkaline perm solution | |
JP2003238341A (en) | Skin care preparation | |
JPH07187985A (en) | Skin-beautifying agent consisting essentially of phytic acid or its salts | |
JPH08169809A (en) | Film type pack | |
JP3592999B2 (en) | Square plug remover | |
JP2001220341A (en) | Cosmetic and method of its use | |
JP2004285036A (en) | Skin conditioning agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080630 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090630 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |